James Greenblatt will review: Evidence-based strategies for its use Safety considerations and potential side effects Blood testing Dosing and best practices Case studies & - #PsychiatryRedefined #FunctionalPsychiatry #LowDoseLithium #NutritionalPsychiatry #FreeWebinar #LithiumOrotate To view or add a comment, sign in I'm glad to share our new retrospective cohort study in The Lancet Obstetrics, Gynaecology & Women's Health on neuropsychiatric and mental health outcomes in hyperemesis gravidarum
The comprehensive recovery stack For maximum recovery support, some practitioners recommend a multi-peptide approach that addresses all major healing pathways simultaneously
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) Small-molecule NNMT inhibitor often discussed with metabolic protocols
Anyone with a history of cancer should regard pro-angiogenic peptides with particular caution
Many peptide vials are sealed under vacuum during manufacturing
Funding for the study came from the National Institutes of Health (grants GM63879, HL107904, HL109442, HL133191, DE023105, and AR066101).